EUROFINS SCIENT Retained Earnings (Accumulated Deficit) 2018-2025 | ERFSF
EUROFINS SCIENT retained earnings (accumulated deficit) from 2018 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- EUROFINS SCIENT retained earnings (accumulated deficit) for the quarter ending June 30, 2025 were $2.913B, a 53.32% increase year-over-year.
- EUROFINS SCIENT retained earnings (accumulated deficit) for 2024 were $2.913B, a 12.44% increase from 2023.
- EUROFINS SCIENT retained earnings (accumulated deficit) for 2023 were $2.591B, a 5.4% increase from 2022.
- EUROFINS SCIENT retained earnings (accumulated deficit) for 2022 were $2.458B, a 5.76% increase from 2021.
| EUROFINS SCIENT Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $2,913 |
| 2023 | $2,591 |
| 2022 | $2,458 |
| 2021 | $2,324 |
| 2020 | $1,497 |
| 2019 | $805 |
| 2018 | $779 |
| 2017 | $591 |
| 2016 | $0 |
| 2015 | $0 |
| EUROFINS SCIENT Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-12-31 | $2,913 |
| 2023-06-30 | $2,465 |
| 2022-12-31 | $2,458 |
| 2021-12-31 | $2,324 |
| 2021-06-30 | $1,900 |
| 2020-12-31 | $1,497 |
| 2020-06-30 | $904 |
| 2019-12-31 | $805 |
| 2019-06-30 | $672 |
| 2018-12-31 | $779 |
| 2018-06-30 | $664 |
| 2017-12-31 | $591 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.851B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.134B | 27.29 |
| CVS Health (CVS) | United States | $76.787B | 9.54 |
| Elevance Health (ELV) | United States | $65.099B | 8.76 |
| Cencora (COR) | United States | $56.278B | 19.58 |
| DiDi Global (DIDIY) | China | $25.745B | 27.35 |
| Labcorp Holdings (LH) | United States | $22.177B | 17.50 |
| Natera (NTRA) | United States | $18.966B | 0.00 |
| BioMerieux (BMXMF) | France | $17.681B | 0.00 |
| ICON (ICLR) | Ireland | $15.102B | 14.53 |
| CochLear (CHEOY) | Australia | $13.402B | 0.00 |
| Solventum (SOLV) | United States | $12.933B | 13.69 |
| Medpace Holdings (MEDP) | United States | $12.571B | 33.27 |
| Revvity (RVTY) | United States | $12.220B | 21.03 |
| Viatris (VTRS) | United States | $11.044B | 3.79 |
| Avantor (AVTR) | United States | $9.683B | 14.07 |
| Sonic Healthcare (SKHHY) | Australia | $9.143B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.690B | 17.03 |
| HealthEquity (HQY) | United States | $8.305B | 36.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.515B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.066B | 29.83 |
| BrightSpring Health Services (BTSG) | United States | $3.609B | 33.11 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Surgery Partners (SGRY) | United States | $2.725B | 35.43 |
| Organon (OGN) | United States | $2.654B | 2.82 |
| Concentras Parent (CON) | United States | $2.520B | 14.56 |
| Alignment Healthcare (ALHC) | United States | $2.327B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.278B | 87.73 |
| Progyny (PGNY) | United States | $1.981B | 43.60 |
| GoodRx Holdings (GDRX) | United States | $1.786B | 35.71 |
| PACS (PACS) | United States | $1.782B | 0.00 |
| Premier (PINC) | United States | $1.744B | 13.23 |
| Ardent Health (ARDT) | United States | $1.582B | 6.74 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.080B | 8.22 |
| QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.853B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.758B | 7.10 |
| CareDx (CDNA) | United States | $0.712B | 11.12 |
| Embecta (EMBC) | United States | $0.686B | 4.62 |
| Nutex Health (NUTX) | United States | $0.528B | 7.99 |
| InnovAge Holding (INNV) | United States | $0.518B | 0.00 |
| Omada Health (OMDA) | $0.495B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.493B | 0.00 |
| LifeMD (LFMD) | United States | $0.486B | 0.00 |
| So-Young (SY) | China | $0.471B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.12 |
| Oncology Institute (TOI) | United States | $0.328B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.284B | 0.00 |
| Beauty Health (SKIN) | United States | $0.226B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.192B | 0.00 |
| DocGo (DCGO) | United States | $0.149B | 24.33 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Biodesix (BDSX) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |